Delivery Order SPE2DB20D3103-SPE2DB25FN4K8

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,243.70 firm fixed-price delivery order is for the supply of 4,568,149,549 units of Indocyanine Green 25 mg vials. The contract has an ultimate completion date of May 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award, with a value of $1,838.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Indocyanine Green 25 mg vials, a medical product, with a completion date of March 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,112.50 delivery order contract is for the supply of Indocyanine Green 25 mg vials, a medical product used in various healthcare applications. The contract has an ultimate completion date of July 25, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,222.50 firm fixed-price delivery order is for the procurement of 4567578457 ! INDOCYANINE GREEN 25 MG VIALS. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,743.22 firm fixed-price delivery order is for the supply of 4,568,252,838 units of Indocyanine Green 25 mg vials, with a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,893.99 firm fixed-price delivery order is for the provision of 4567765831 Indocyanine Green 25 mg vials. This contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,222.50 firm fixed-price delivery order covers the supply of 4566682363 - Indocyanine Green 25 mg vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valid through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.00 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FDPP3) is for the supply of Indocyanine Green 25 mg vials, with a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,768.28 Firm Fixed Price delivery order is for the procurement of 4566963296 - Indocyanine Green 25 mg Vials. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.05 firm-fixed-price delivery order is for the supply of 25 mg vials of Indocyanine Green, a medical product used in various clinical applications. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN4K8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,368.68 firm fixed-price delivery order is for the supply of 4,567,923,799 units of Indocyanine Green 25 mg vials. The contract has an ultimate completion date of April 16, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. This award positions Amerisourcebergen Drug Corp as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/15/25, 4:08 PM